$UHS

Universal Health Services Reports Q3 Revenue Growth, $5.22 Diluted EPS

Universal Health Services reported Q3 2026 revenue of $4.73B, up 5.3% YoY, and net income of $308.7M. Diluted EPS was $5.22. Nine-month revenue grew 7.7% to $13.87B. The company completed its acquisition of Talkspace in August 2026.

Original reporting
Published Oct 27, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 9:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Universal Health Services Reports Q3 Revenue Growth, $5.22 Diluted EPS — source image
Decision brief

The 30-second read

$UHSNeutralMed
01

Why it matters

The earnings beat on revenue but miss on operating income may lead to a muted market reaction, with investors focusing on margin trends and the Talkspace integration.

02

Market read

UHS earnings provide fresh data for healthcare sector investors; the mixed results could influence short‑term trading strategies.

03

What to watch

Acquisition of Talkspace may introduce integration risk and affect future earnings quality.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

The article summarizes Universal Health Services' Q3 2026 earnings release filed via an SEC 8‑K, highlighting revenue, earnings, and recent acquisition.

Company-level read

Ticker impact

$UHSNeutralHigh confidence
Context

Universal Health Services disclosed Q3 2026 revenue of $4.73B and EPS of $5.22 in its 8‑K filing.

Expected impact

likely modest pressure as investors weigh higher revenue against lower operating income

Evidence & confidence

Revenue beat suggests growth, but declining operating income could temper upside, leading to a sideways to slightly down reaction.

Market effects

Healthcare services sector may see modest uplift from UHS revenue growth, but profit margin concerns could limit broader impact.

UHS is a U.S. provider; impact confined to U.S. healthcare equities.

Limited, as the news pertains to a single U.S. company without global macro implications.

Counterpoint

Investors could short UHS if they believe operating margin compression signals deeper operational issues.

Key entities

  • Universal Health Services

    U.S. healthcare services provider (ticker UHS).

Related articles

$UHSHigh

Universal Health Services falls 3% on legal settlement concerns

Universal Health Services (UHS) reported Q3 earnings of $5.22 per share, beating estimates by $0.02, with revenue up 5.3% YoY to $4.73B. Shares fell 3% after-hours due to legal settlement costs and Medicaid payment uncertainties. The quarter included a $26M charge for a tentative settlement in Cumberland Hospital litigation, partially offset by a $21M Medicaid payment benefit. UHS repurchased 1.35M shares at $242.1M.

$UHSHigh

UNIVERSAL HEALTH SERVICES INC (UHS): ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2026

UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE October 27, 2026 CONTACT: Darren Lehrich Vice President-Investor Relations 610-382-3310 Darren.Lehrich@uhsinc.com UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2026 Consolida

$UHSHighAI 8/10

Universal Health Services (NYSE:UHS) posts Q3 2026 sales in line with estimates

Universal Health Services (UHS) reported Q3 2026 revenue of $4.73 billion, matching estimates and showing 5.3% year-on-year growth. Adjusted EPS beat estimates at $5.22, while adjusted EBITDA missed at $624.6 million. Operating margin declined to 9.6% from 11.6% year-on-year, but free cash flow margin improved to 8.9% from 3.4%. Same-store sales rose 4.7% year-on-year, up from 2% in the prior year quarter.